Intrathecal Morphine Infusion Therapy via a Percutaneous Port for Refractory Cancer Pain in China: An Efficacy, Safety and Cost Utilization Analysis

MLA

Qin W, et al. “Intrathecal Morphine Infusion Therapy via a Percutaneous Port for Refractory Cancer Pain in China: An Efficacy, Safety and Cost Utilization Analysis.” Journal of Pain Research, vol. ume 13, Jan. 2020, pp. 231–37. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.426f33a180d14c419168b3f7bec08baf&authtype=sso&custid=ns315887.

APA

Qin W, Li Y, Liu B, Liu Y, Zhang Y, Zhang X, Li P, & Fan B. (2020). Intrathecal Morphine Infusion Therapy via a Percutaneous Port for Refractory Cancer Pain in China: An Efficacy, Safety and Cost Utilization Analysis. Journal of Pain Research, ume 13, 231–237.

Chicago

Qin W, Li Y, Liu B, Liu Y, Zhang Y, Zhang X, Li P, and Fan B. 2020. “Intrathecal Morphine Infusion Therapy via a Percutaneous Port for Refractory Cancer Pain in China: An Efficacy, Safety and Cost Utilization Analysis.” Journal of Pain Research ume 13 (January): 231–37. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.426f33a180d14c419168b3f7bec08baf&authtype=sso&custid=ns315887.